...
首页> 外文期刊>Serbian Journal of Experimental and Clinical Research >The Effect of the Antioxidant Drug U-74389G on Uric Acid Levels during Ischemia Reperfusion Injury in Rats
【24h】

The Effect of the Antioxidant Drug U-74389G on Uric Acid Levels during Ischemia Reperfusion Injury in Rats

机译:抗氧化剂U-74389G对大鼠缺血再灌注损伤过程中尿酸水平的影响

获取原文
   

获取外文期刊封面封底 >>

       

摘要

This experimental study examined the effect of the anti-oxidant drug U-74389G in a rat model using a renal ischaemia-reperfusion (IR) protocol. The effects of the molecule were studied biochemically by assessing mean serum uric acid levels (SUA). In total, 40 rats (mean weight = 231.875 g) were used in the study. SUA levels were measured at 60 min of reperfusion for groups A and C and at 120 min of reperfusion for groups B and D. The drug U-74389G was administered only in groups C and D. U-74389G administration non-significantly increased the SUA levels by 15.43%±9.10% (p=0.096) at the representative endpoint of 1.5 h. The reperfusion time non-significantly decreased the SUA levels by 13.61%±9.18% (p=0.126). However, the interaction of U-74389G administration and reperfusion time non-significantly increased the SUA levels by 4.78%±5.64% (p= 0.387). Whether it interacted with the reperfusion time, U-74389G administration non-significantly increased SUA levels. It seems that U-74389G cannot reverse injury to IR tubular epithelial cells within 2 hours.
机译:这项实验研究使用肾脏缺血再灌注(IR)方案检查了抗氧化剂U-74389G在大鼠模型中的作用。通过评估平均血清尿酸水平(SUA)生化研究了该分子的作用。该研究总共使用了40只大鼠(平均体重= 231.875 g)。在A和C组再灌注60分钟以及B和D组再灌注120分钟时测量SUA水平。仅在C和D组中使用药物U-74389G。U-74389G给药无明显增加SUA在1.5 h的代表性终点时水平下降15.43%±9.10%(p = 0.096)。再灌注时间无显着降低SUA水平13.61%±9.18%(p = 0.126)。但是,U-74389G的给药和再灌注时间之间的相互作用无显着增加SUA水平4.78%±5.64%(p = 0.387)。无论是否与再灌注时间相互作用,U-74389G的给药均不会显着增加SUA水平。似乎U-74389G无法在2小时内逆转对IR肾小管上皮细胞的损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号